Private CTAK keratoconus corneal tissue surgery, UK 2026

What is CTAK and how does it work?

Keratoconus is a condition in which the cornea — the clear front window of the eye — progressively thins and bulges into a cone shape. That irregular shape scatters light, so vision becomes distorted and hard to correct with glasses; many patients end up dependent on rigid contact lenses, and some eventually face a corneal transplant. CTAK (corneal tissue addition keratoplasty) is a relatively new, tissue-additive way to improve the shape of such a cornea.

The principle is simple but clever. A shaped piece of natural corneal stroma — an allogenic (donor) lenticule, often one of the tissue lenticules produced as a by-product of a SMILE laser vision-correction procedure — is prepared to a specific size and profile to match your individual cone. A femtosecond laser then creates a precise pocket within the layers of your own cornea, through a tiny access incision and without removing any of your tissue. The prepared lenticule is slid into that pocket and positioned in relation to the cone, so that adding tissue in the right place flattens the bulge and makes the front surface of the cornea more regular.

Because CTAK uses natural tissue, can be tailored to each eye, removes none of the host cornea and can in principle be repositioned, exchanged or removed, it is described as tissue-additive and potentially reversible. Crucially, it does not burn any bridges: if a transplant is ever needed in the future, CTAK does not prevent it. It is best thought of as a shape-improving step on the keratoconus treatment ladder, sitting between contact lenses and more invasive options.

CTAK is usually performed on a cornea whose disease has already been stabilised with corneal cross-linking, because cross-linking is the treatment that halts progression while CTAK improves shape. If you are still researching your options, you may also want to read about private corneal cross-linking, the keratoconus transplant procedure DALK, and the broader treatments directory.

UK 2026 CTAK pricing, in detail

Below is a typical UK 2026 private fee structure for CTAK at a CQC-registered centre. Because CTAK is an emerging specialist procedure offered by a limited number of corneal surgeons, prices vary more than for established operations, and corneal cross-linking (if your cornea is not yet stabilised) is normally costed separately.

For comparison with other corneal procedures, see private corneal transplant (DMEK) cost and ultra-thin DSAEK endothelial graft. If your keratoconus is mild and your main goal is reducing glasses dependence, options such as implantable collamer lenses (ICL) may also be discussed in selected, stable cases.

What a quality UK CTAK package should include

CTAK is a specialist procedure, so the quality of the assessment and planning matters as much as the surgery. Check that a private quote covers each of the following.

• Consultant corneal specialist — a GMC-registered consultant ophthalmologist with a completed cornea and refractive fellowship who manages the full keratoconus pathway.
• Full corneal tomography and epithelial mapping — detailed Scheimpflug or OCT imaging to locate and quantify the cone and plan the lenticule.
• Confirmation of disease stability — documentation that the keratoconus is stable or a clear plan for cross-linking before or alongside CTAK.
• Traceable, sterile allogenic lenticule — properly sourced and prepared corneal tissue with full traceability.
• Femtosecond-laser pocket creation — precise, depth-controlled stromal pocket rather than a manual dissection.
• CQC-registered day-case theatre — a registered ophthalmic theatre with appropriate sterility.
• Honest discussion of evidence — a frank explanation that CTAK is an emerging procedure and how it compares to ring segments and transplant.
• Post-operative drop regimen — a written schedule of antibiotic and anti-inflammatory drops and lubricants.
• Tomography-based follow-up — repeat imaging to confirm flattening and lenticule stability over the first months.
• Refractive refinement plan — a clear plan for glasses or contact-lens fitting once the cornea is stable.
• Long-term keratoconus monitoring — an ongoing surveillance pathway, because keratoconus is lifelong.
• Itemised invoice for your insurer — clinical justification and procedure detail to support a claim.

Evidence base — what the CTAK literature shows

CTAK is a newer technique, so its evidence base is smaller and shorter-term than long-established keratoconus surgery. It builds, however, on well-validated foundations: corneal cross-linking, femtosecond-laser corneal surgery and allogenic stromal tissue work.

• Original CTAK description — the corneal tissue addition keratoplasty technique was described by Jacob and colleagues, using a shaped allogenic lenticule in a femtosecond pocket to flatten the keratoconic cone.
• Allogenic intrastromal lenticule literature — a growing body of work on implanting donor corneal lenticules (including SMILE-derived tissue) to add tissue and reshape ectatic corneas.
• Corneal cross-linking evidence (Dresden protocol) — Wollensak and colleagues established that riboflavin-UVA cross-linking halts keratoconus progression; CTAK addresses shape on a stabilised cornea.
• Intrastromal corneal ring segment data — decades of evidence for synthetic ring segments provide the comparator against which tissue-additive flattening is judged.
• Femtosecond-laser corneal surgery — extensive validation of femtosecond pocket and channel creation for predictable, depth-controlled lamellar surgery.
• Keratoconus staging frameworks — Amsler-Krumeich and tomography-based classifications guide patient selection and outcome reporting.
• Royal College of Ophthalmologists corneal guidance — frames the overall keratoconus pathway from cross-linking and contact lenses to surgical options.
• Eye-banking and tissue-preparation standards — standards for sourcing, processing and tracing allogenic corneal tissue used in lamellar procedures.
• Emerging comparative series — early published case series and registries continue to report keratometric and visual outcomes after tissue-additive keratoplasty.

CTAK versus the other keratoconus options

Keratoconus care is a ladder, and CTAK is one rung on it. The right choice depends on whether the disease is active, how irregular the cornea is, whether there is central scarring, and how well you tolerate contact lenses.

• Corneal cross-linking (CXL) — the treatment that halts progression by stiffening the cornea. It is not a competitor to CTAK but a partner: most patients are cross-linked first, then have CTAK to improve shape.
• Intrastromal corneal ring segments (ICRS/Intacs) — synthetic arcs placed in stromal channels to flatten the cone. Well-established with long-term data; CTAK is the tissue-additive, customisable alternative.
• Rigid gas-permeable and scleral contact lenses — the non-surgical mainstay; they neutralise corneal irregularity optically. CTAK is most useful when these become intolerable or insufficient.
• Deep anterior lamellar keratoplasty (DALK) — a partial-thickness transplant replacing the diseased stroma but keeping the patient's inner layer; reserved for advanced disease or central scarring. More invasive than CTAK.
• Penetrating keratoplasty — full-thickness transplant; now less commonly needed for keratoconus thanks to cross-linking and lamellar techniques.
• Topography-guided surface laser (with CXL) — a small, carefully limited laser treatment to regularise the surface in selected stable eyes; a different approach to improving shape.
• Phakic intraocular lenses (ICL) — address refractive error rather than corneal shape; sometimes used in stable keratoconus with reasonable corneal regularity to reduce glasses dependence.
• Observation — appropriate for mild, stable keratoconus with good spectacle or lens-corrected vision and no progression.

Who is private CTAK the right choice for?

CTAK is aimed at improving the shape and vision of a keratoconic cornea that has been stabilised but remains too irregular for comfortable, effective spectacle or soft-lens vision. The clearest candidates are below.

• Stabilised keratoconus with an irregular cornea — disease halted (usually by cross-linking) but vision still limited by corneal shape.
• Contact-lens intolerance — patients who can no longer comfortably wear rigid or scleral lenses.
• Wish to avoid synthetic ring segments — those who prefer a natural-tissue, customisable approach.
• Eyes heading towards transplant mainly because of shape — where poor regularity, not central scarring, is the main problem.
• Adequate corneal thickness and no central scar — enough stroma to create a safe pocket and a clear visual axis.
• Realistic expectations — understanding that CTAK improves shape and vision but does not guarantee freedom from glasses or lenses.
• Selected post-refractive ectasia or pellucid marginal degeneration — some non-keratoconus ectasias may be considered case by case.
• Able to attend follow-up — willing to return for the tomography-based monitoring CTAK requires.

CTAK is generally not appropriate where vision is limited by central corneal scarring (which a transplant addresses), where the cornea is too thin or anatomically unsuitable for a safe pocket, where progression is active and unstabilised, or where eye-rubbing and atopy are uncontrolled.

NHS versus private CTAK

On the NHS, keratoconus is managed with corneal cross-linking to halt progression, contact-lens fitting, intrastromal ring segments in some centres, and corneal transplant for advanced disease. CTAK is an emerging, specialist procedure offered at a small number of centres and is not part of routine NHS keratoconus pathways, so most patients who want it will access it privately, where a corneal surgeon who performs the technique can assess them.

The private advantage here is access and expertise rather than simply speed: you are seen by a consultant who offers the full range of keratoconus options, has the corneal tomography to plan a bespoke lenticule, and can be honest about whether CTAK, ring segments, continued contact lenses or a transplant is the most appropriate next step for your eye. Cross-linking to stabilise the disease is widely available on the NHS and privately, and a sensible plan often combines NHS or private stabilisation with private shape-correcting surgery.

Whatever route you choose, the long-term need for keratoconus monitoring does not change: the cornea must be watched over the years for any sign of progression, and that surveillance can be shared between your optometrist, an NHS clinic and the private team.

Private medical insurance and CTAK

Because CTAK is a newer procedure, insurer coverage is less standardised than for established corneal surgery, and it is important to check your specific policy and obtain pre-authorisation before booking. The major UK insurers — Bupa, AXA Health, Aviva, Vitality and WPA — assess such procedures against medical necessity and their own coding; some may cover CTAK as a reconstructive corneal procedure for keratoconus, while others may treat the corneal stabilisation (cross-linking) and shape-correction components differently. The clinic's administrative team can provide the clinical justification, tomographic findings and procedure detail your insurer needs, and will tell you in advance what is likely to be covered and what may be self-pay so there are no surprises.

Risks of CTAK

CTAK is designed to be lower-risk than a corneal transplant because it adds tissue into a pocket rather than replacing the cornea, and it removes none of your own tissue. Risks are nonetheless real and, as with any newer procedure, long-term data are still being gathered.

• Under- or over-correction of shape — the cornea may flatten less or more than planned, sometimes needing adjustment or a different lenticule.
• Lenticule decentration — a lenticule that sits slightly off the ideal position relative to the cone can give a suboptimal optical result.
• Interface haze or deposits — mild haze or deposits can occur at the tissue interface, occasionally affecting vision.
• Residual irregularity — some eyes still need contact lenses for best vision even after a successful shape improvement.
• Infection — as with any intraocular or intrastromal surgery, infection is a rare but serious risk, minimised by sterile technique and antibiotic cover.
• Delayed epithelial healing — the surface over the access incision can take longer to heal in some eyes, prolonging discomfort.
• Need for adjustment or removal — the lenticule may need repositioning, exchange or removal; the tissue-additive design makes this feasible.
• Continued progression if not cross-linked — CTAK does not stop keratoconus; an unstabilised cornea can continue to worsen.
• Uncertain very-long-term outcome — as an emerging procedure, multi-year comparative data are still maturing.
• Need for transplant later — if the cornea scars or disease advances, a transplant may still be required — though CTAK does not prevent one.

Recovery after CTAK

CTAK is a day-case procedure, and most patients go home shortly after surgery. The eye is typically a little sore, gritty and watery for the first day or two while the surface epithelium heals over the small access incision; a bandage contact lens and frequent preservative-free lubricants help considerably during this phase. Light sensitivity and a feeling that something is in the eye are common early on and settle as the surface heals.

Vision after CTAK usually fluctuates for several weeks. This is expected: the cornea is gradually settling into its new, flatter and more regular shape, and the visual result improves and stabilises over weeks to a few months rather than overnight. It is wise to plan for this and not to judge the outcome in the first days. You will use antibiotic drops short-term and an anti-inflammatory (steroid) drop on a reducing schedule, exactly as directed.

For the first one to two weeks, avoid rubbing the eye (eye-rubbing is particularly harmful in keratoconus), swimming, hot tubs and dusty environments, and avoid eye make-up until the surface has healed. Most people return to office work within a few days to a week, depending on comfort and vision; discuss driving and any visually demanding or dirty work with your surgeon.

Once the cornea is stable, your team will refine your glasses or fit contact lenses to make the most of the improved corneal shape. Contact the clinic promptly if you develop increasing pain, increasing redness, discharge, or a sudden drop in vision — these can indicate infection or a problem with the lenticule and need to be seen quickly. As with all keratoconus care, lifelong monitoring with periodic tomography continues to confirm that the cornea remains stable.

How to choose a UK clinic for CTAK

Because CTAK is specialised and the evidence base is still developing, surgeon experience and honest counselling matter even more than usual. Look for the following.

• Fellowship-trained corneal consultant — a GMC-registered consultant with a completed cornea and refractive fellowship who manages keratoconus across the whole pathway.
• A full keratoconus menu — a surgeon who also offers cross-linking, ring segments and transplant can recommend CTAK only when it is genuinely the best option.
• Advanced corneal imaging — Scheimpflug and OCT tomography with epithelial mapping for accurate planning and follow-up.
• Femtosecond-laser capability — the precise pocket creation that CTAK depends on.
• Reliable tissue sourcing — properly processed, traceable allogenic corneal lenticules.
• CQC inspection rating — check the Care Quality Commission report; look for Good or Outstanding on Safe and Effective.
• Transparent counselling — a clinic that explains the emerging-evidence status of CTAK and sets realistic expectations.
• A clear monitoring pathway — tomography-based follow-up and lifelong keratoconus surveillance.
• Transparent pricing — a written quote separating assessment, procedure, tissue and follow-up, with cross-linking costed clearly.

You can read more about our surgeons on the our surgeons page, browse all treatments, or explore related eye conditions.

Frequently asked questions

Methodology and sources

This page is built from the published description of the CTAK technique, the wider literature on allogenic corneal lenticules, cross-linking and femtosecond corneal surgery, UK and international corneal guidance, and the practical experience of UK CQC-registered corneal services. Where prices are quoted they reflect typical UK 2026 self-pay rates observed at the time of publication; because CTAK is an emerging procedure, ranges are wider than for established surgery.

• Jacob S et al. Corneal tissue addition keratoplasty (CTAK) for keratoconus using a shaped allogenic stromal lenticule. Journal of Refractive Surgery.
• Literature on allogenic intrastromal corneal lenticule implantation, including SMILE-derived tissue, for corneal ectasia.
• Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen cross-linking for the treatment of keratoconus (Dresden protocol).
• Intrastromal corneal ring segment outcome literature for comparator context.
• Femtosecond-laser corneal lamellar surgery validation studies.
• Amsler-Krumeich and tomography-based keratoconus staging frameworks.
• Royal College of Ophthalmologists guidance on keratoconus and corneal surgery.
• Eye-banking and corneal tissue preparation and traceability standards.
• Care Quality Commission inspection reports for UK ophthalmic day-case providers.

This page is editorial and educational. It is not personalised medical advice. Suitability for CTAK, the need for prior corneal cross-linking, the choice between CTAK, ring segments, contact lenses and transplant, and the expected outcomes are individual decisions made between you and a GMC-registered consultant corneal surgeon following a full clinical assessment with corneal tomography. Prices are typical UK 2026 ranges at CQC-registered centres and may vary.

Book your keratoconus consultation

If keratoconus is making your vision distorted or your contact lenses hard to tolerate, a corneal specialist can tell you whether CTAK — or cross-linking, ring segments or another option — is right for your eye. We offer same-week consultant corneal assessment at CQC-registered UK centres, detailed corneal tomography at one visit, and honest, expectation-setting advice. Our consultants are GMC-registered cornea and refractive specialists with substantive NHS posts, completed corneal fellowships and Royal College of Ophthalmologists subspecialty training. Call us or use the appointment form.

Related reading: Corneal cross-linking cost · DALK keratoconus transplant · DMEK corneal transplant cost · EVO ICL for high myopia · All treatments